Two Sigma Advisers’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,500
| Closed | -$178K | – | 2524 |
|
|
2024
Q3 | $178K | Sell |
14,500
-5,200
| -26% | -$63.9K | ﹤0.01% | 2097 |
|
|
2024
Q2 | $266K | Buy |
+19,700
| New | +$266K | ﹤0.01% | 2121 |
|
|
2024
Q1 | – | Sell |
-11,000
| Closed | -$57.9K | – | 2632 |
|
|
2023
Q4 | $57.9K | Sell |
11,000
-2,800
| -20% | -$14.7K | ﹤0.01% | 2390 |
|
|
2023
Q3 | $54.4K | Buy |
+13,800
| New | +$54.4K | ﹤0.01% | 2271 |
|
|
2023
Q1 | – | Sell |
-36,600
| Closed | -$338K | – | 2742 |
|
|
2022
Q4 | $338K | Buy |
36,600
+11,000
| +43% | +$102K | ﹤0.01% | 2027 |
|
|
2022
Q3 | $329K | Buy |
25,600
+7,000
| +38% | +$90K | ﹤0.01% | 2008 |
|
|
2022
Q2 | $246K | Sell |
18,600
-100
| -0.5% | -$1.32K | ﹤0.01% | 2195 |
|
|
2022
Q1 | $394K | Sell |
18,700
-21,300
| -53% | -$449K | ﹤0.01% | 2103 |
|
|
2021
Q4 | $960K | Sell |
40,000
-41,100
| -51% | -$986K | ﹤0.01% | 1576 |
|
|
2021
Q3 | $2.06M | Buy |
81,100
+33,500
| +70% | +$852K | 0.01% | 1232 |
|
|
2021
Q2 | $1.6M | Buy |
47,600
+23,000
| +93% | +$774K | ﹤0.01% | 1413 |
|
|
2021
Q1 | $955K | Buy |
+24,600
| New | +$955K | ﹤0.01% | 1673 |
|